Principal Financial Group Inc Allogene Therapeutics, Inc. Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$2.23 - $4.38 $31,075 - $61,035	-13,935 Reduced 45.29%	16,836 $39,000
Q1 2024 Apr 29, 2024	SELL	$2.92 - $5.63 $11,218 - $21,630	-3,842 Reduced 11.1%	30,771 $137,000
Q4 2023 Feb 07, 2024	SELL	$2.28 - $3.5 $527,913 - $810,393	-231,541 Reduced 87.0%	34,613 $111,000
Q3 2023 Nov 02, 2023	BUY	$3.17 - $5.96 $14,363 - $27,004	4,531 Added 1.73%	266,154 $843,000
Q2 2023 Aug 07, 2023	BUY	$4.53 - $6.74 $4,507 - $6,706	995 Added 0.38%	261,623 $1.3 Million
Q1 2023 May 09, 2023	BUY	$4.92 - $8.21 $48,063 - $80,203	9,769 Added 3.89%	260,628 $1.29 Million
Q4 2022 Feb 09, 2023	BUY	$5.62 - $11.11 $13,015 - $25,730	2,316 Added 0.93%	250,859 $1.58 Million
Q3 2022 Nov 09, 2022	BUY	$10.32 - $17.28 $74,923 - $125,452	7,260 Added 3.01%	248,543 $2.68 Million
Q2 2022 Aug 10, 2022	BUY	$6.78 - $12.28 $27,621 - $50,028	4,074 Added 1.72%	241,283 $2.75 Million
Q1 2022 May 09, 2022	SELL	$7.65 - $15.29 $6,946 - $13,883	-908 Reduced 0.38%	237,209 $2.16 Million
Q4 2021 Feb 09, 2022	BUY	$13.13 - $24.52 $1.27 Million - $2.38 Million	97,060 Added 68.81%	238,117 $3.55 Million
Q3 2021 Nov 09, 2021	SELL	$21.01 - $27.64 $18,446 - $24,267	-878 Reduced 0.62%	141,057 $3.63 Million
Q2 2021 Aug 10, 2021	BUY	$23.49 - $35.8 $84,728 - $129,130	3,607 Added 2.61%	141,935 $3.7 Million
Q1 2021 May 10, 2021	BUY	$25.79 - $39.02 $353,993 - $535,588	13,726 Added 11.02%	138,328 $4.88 Million
Q4 2020 Feb 08, 2021	BUY	$25.24 - $43.45 $350,684 - $603,694	13,894 Added 12.55%	124,602 $3.15 Million
Q3 2020 Nov 06, 2020	BUY	$32.38 - $44.96 $84,544 - $117,390	2,611 Added 2.42%	110,708 $4.17 Million
Q2 2020 Aug 05, 2020	SELL	$18.39 - $54.04 $497,780 - $1.46 Million	-27,068 Reduced 20.03%	108,097 $4.63 Million
Q1 2020 May 12, 2020	BUY	$18.22 - $28.25 $13,701 - $21,244	752 Added 0.56%	135,165 $2.63 Million
Q4 2019 Feb 05, 2020	SELL	$24.82 - $31.4 $22,288 - $28,197	-898 Reduced 0.66%	134,413 $3.49 Million
Q3 2019 Nov 13, 2019	BUY	$26.11 - $32.99 $3,812 - $4,816	146 Added 0.11%	135,311 $3.69 Million
Q2 2019 Aug 12, 2019	BUY	$25.56 - $31.09 $1.96 Million - $2.38 Million	76,665 Added 131.05%	135,165 $3.63 Million
Q1 2019 May 10, 2019	SELL	$24.82 - $32.54 $143,956 - $188,732	-5,800 Reduced 9.02%	58,500 $1.69 Million
Q4 2018 Feb 14, 2019	BUY	$22.5 - $33.3 $1.45 Million - $2.14 Million	64,300 New	64,300 $1.73 Million

Others Institutions Holding ALLO

# of Institutions

162

Shares Held

134M

Call Options Held

59.4K

Put Options Held

113K

View Full List

About Allogene Therapeutics, Inc.

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

More about ALLO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account